Home Strains Research Conditions Breeders Compare Explorer Blog

Command Palette

Search for a command to run...

The world's most comprehensive cannabis strain directory, backed by scientific research.

Explore

Strain Directory Indica Strains Sativa Strains Hybrid Strains Breeders

Research

Research Database Medical Conditions Pain Relief Anxiety Insomnia

Tools

Strain Comparator Strain Explorer Blog API

© 2026 BudProfiles. For informational and educational purposes only.

Privacy Policy Terms of Service Disclaimer

11,121 strains · 12,304 studies · 268 breeders

Best Cannabis Strains for Epilepsy - Lennox-Gastaut — 0 Strains, 0 Studies | BudProfiles

Home

Conditions

Epilepsy - Lennox-Gastaut

Cannabis & Epilepsy - Lennox-Gastaut

Explore 0 strains and 0 scientific studies related to Epilepsy - Lennox-Gastaut.

0

Strains

0

Studies

14

Positive Studies

78%

Evidence Score

Research Evidence

14

Positive (70.0%)

1

Negative (5.0%)

5

Inconclusive (25.0%)

Scientific Studies

Management of Lennox-Gastaut Syndrome with a CBD/THC Isolate Combination

2025·Review/Other

Biotechnological Fungal Platforms for the Production of Biosynthetic Cannabinoids

2023·Review/Other

Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis

2023·Meta-analysis -

Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance

2023·Review/Other

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

2023·Review/Other

Use of non-medical cannabis in epilepsy: A scoping review

2023·Review/Other

Seizure-free days as a novel outcome in patients with Lennox-Gastaut syndrome: Post hoc analysis of patients receiving cannabidiol in two randomized controlled trials

2023·Double Blind Clinical Trial

Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study

2023·Review/Other

Could cannabinoids provide a new hope for ovarian cancer patients?

2023·Review/Other

Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends

2023·Review/Other

Establishment of a point of departure for CBD hepatotoxicity employing human HepaRG spheroids

2023·Review/Other

A Rare Case of Cannabinoid Hyperemesis Syndrome Secondary to Cannabidiol for Refractory Epilepsy

2023·Review/Other

Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review

2022·Meta-analysis -

Movement Disorders Secondary to Novel Antiseizure Medications in Pediatric Populations: A Systematic Review and Meta-analysis of Risk

2022·Meta-analysis -

Adjunctive Transdermal Cannabidiol for Adults With Focal Epilepsy: A Randomized Clinical Trial

2022·Clinical Trial

Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants

2022·Laboratory Study -

Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

2022·Meta-analysis -

Effects of short-term environmental stresses on the onset of cannabinoid production in young immature flowers of industrial hemp (Cannabis sativa L.)

2022·Clinical Trial

TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids

2022·Review/Other

Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex

2022·Review/Other